Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.87%12.16M | 5.19%10.22M | 21.65%11.66M | 6.77%47.6M | 7.55%17.14M | 26.58%11.17M | 2.80%9.72M | -7.53%9.59M | -56.50%44.58M | 58.03%15.94M |
| Cost of revenue | -10.28%8.65M | 22.85%8.61M | 12.89%8.17M | 27.98%36.55M | 3.75%9.72M | 41.80%9.64M | 18.83%7.01M | 9.71%7.23M | -67.40%28.56M | 29.47%9.37M |
| Gross profit | 129.33%3.51M | -40.61%1.61M | 48.60%3.5M | -31.04%11.05M | 12.98%7.42M | -24.43%1.53M | -23.83%2.7M | -37.66%2.35M | 7.62%16.02M | 130.53%6.57M |
| Operating expense | -90.39%803K | 111.71%10.01M | -37.88%5.48M | 173.61%48.99M | 1,260.54%25.37M | 852.16%8.36M | -57.04%4.73M | 112.52%8.83M | -58.04%17.91M | -54.32%1.87M |
| Selling and administrative expenses | 22.68%5.1M | 4.32%4.01M | 41.65%5.18M | 38.40%18.63M | 47.85%6.12M | 22.95%4.16M | 25.70%3.84M | 26.70%3.65M | -33.63%13.46M | 3.53%4.14M |
| -Selling and marketing expense | -39.92%569K | 26.47%774K | 72.53%804K | 111.22%3.6M | 183.98%1.38M | 169.03%947K | 31.90%612K | 15.63%466K | -22.39%1.71M | 54.11%487K |
| -General and administrative expense | 41.15%4.53M | 0.12%3.24M | 37.14%4.37M | 27.84%15.03M | 29.68%4.73M | 5.98%3.21M | 24.60%3.23M | 28.50%3.19M | -35.00%11.75M | -0.82%3.65M |
| Other operating expenses | ---- | 268.65%7.81M | -82.49%1.11M | 479.75%33.33M | --19.54M | 300.18%4.42M | -73.53%2.12M | 253.68%6.34M | -77.60%5.75M | ---- |
| Total other operating income | 1,898.60%4.3M | 46.43%1.8M | -31.10%802K | 127.54%2.96M | -87.49%284K | -27.36%215K | 2,269.23%1.23M | 122.99%1.16M | -60.21%1.3M | 1,183.05%2.27M |
| Operating profit | 139.65%2.71M | -315.00%-8.41M | 69.29%-1.99M | -1,912.49%-37.94M | -481.53%-17.95M | -694.86%-6.83M | 72.84%-2.03M | -1,599.74%-6.48M | 93.22%-1.89M | 481.59%4.71M |
| Net non-operating interest income (expenses) | -40.05%-549K | -83.07%-703K | -102.65%-841K | -155.01%-1.73M | -62.50%-455K | -280.58%-392K | -284.00%-384K | -332.29%-415K | -47.72%-679.92K | -185.71%-280K |
| Non-operating interest expense | 40.05%549K | 83.07%703K | 102.65%841K | 155.01%1.73M | 62.50%455K | 280.58%392K | 284.00%384K | 332.29%415K | 47.72%679.92K | 185.71%280K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Special income (charges) | 86.83%-93K | -455.09%-593K | 0 | -1,175.27%-4.14M | -562.95%-1.84M | -706K | 718.52%167K | -1,580.00%-336K | -104.74%-324.82K | -117.52%-278K |
| Less:Write off | -86.83%93K | 455.09%593K | --0 | 1,175.27%4.14M | 562.95%1.84M | --706K | -718.52%-167K | 1,580.00%336K | 104.74%324.82K | 117.52%278K |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 126.06%2.07M | -332.63%-9.7M | 60.84%-2.83M | -1,416.19%-43.82M | -588.28%-20.25M | -858.56%-7.93M | 70.43%-2.24M | -1,354.12%-7.23M | 86.49%-2.89M | 1,532.68%4.15M |
| Income tax | 0 | 0 | 0 | -160.45%-2.47M | -99.41%24K | 0 | 136K | 0 | 563.63%4.09M | 439.11%4.09M |
| Net income | 126.06%2.07M | -307.90%-9.7M | 60.84%-2.83M | -492.12%-41.35M | -36,960.00%-20.27M | -858.56%-7.93M | 68.64%-2.38M | -1,354.12%-7.23M | 65.95%-6.98M | -96.24%55K |
| Net income continuous operations | 126.06%2.07M | -307.90%-9.7M | 60.84%-2.83M | -492.12%-41.35M | -36,960.00%-20.27M | -858.56%-7.93M | 68.64%-2.38M | -1,354.12%-7.23M | 65.95%-6.98M | -96.24%55K |
| Noncontrolling interests | -9,000.00%-91K | -490.00%-39K | 40.00%7K | -909.94%-52.65K | -727.27%-69K | 92.31%-1K | 600.00%10K | 600.00%5K | 95.07%-5.21K | 123.91%11K |
| Net income attributable to the company | 127.21%2.16M | -304.56%-9.67M | 60.77%-2.84M | -491.80%-41.29M | -46,018.18%-20.2M | -849.15%-7.93M | 68.50%-2.39M | -1,358.06%-7.23M | 65.80%-6.98M | -97.08%44K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 127.21%2.16M | -304.56%-9.67M | 60.77%-2.84M | -491.80%-41.29M | -46,018.18%-20.2M | -849.15%-7.93M | 68.50%-2.39M | -1,358.06%-7.23M | 65.80%-6.98M | -97.08%44K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 127.45%0.0056 | -301.61%-0.0249 | 60.75%-0.0073 | -388.07%-0.1064 | -52,200.00%-0.0521 | -477.78%-0.0204 | 80.13%-0.0062 | -3,620.00%-0.0186 | 94.55%-0.0218 | -99.32%0.0001 |
| Diluted earnings per share | 127.45%0.0056 | -301.61%-0.0249 | 60.75%-0.0073 | -388.07%-0.1064 | -52,200.00%-0.0521 | -477.78%-0.0204 | 80.13%-0.0062 | -3,620.00%-0.0186 | 94.55%-0.0218 | -99.30%0.0001 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.